NP47825 Multiple Sclerosis Medicines
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-04ce0632014L0024closed for bids
Estimated value
£51.5m
goods
Awarded value
—
Suppliers
0
Lots
2
0 awarded
Published
07 Jan 2025
Deadline 07 Feb 2025
Description
Supply of multiple sclerosis medicines to NHS Scotland.
Scope
- Reference
- ocds-h6vhtk-04ce06
- Total value
- £51,517,832 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Technical (Supply Chain) | 5 | quality | — |
| — | 95 | price | — |
Submission & procedure
- Submission deadline
- 07 Feb 2025, 12:00 pm
- Submission address
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ↗
- Procedure
- Open procedure
Lots · 2 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 2 | Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules | £2.2m | active |
| 1 | Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab | £49.3m | active |